Register entry
Alnylam Pharmaceuticals, Inc.
- Registered sites
- 2
- Drug products
- 4
- Live patents
- 48
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureFinished drug manufacture
Sites
Facilities
2| Site | Location | Operations | FEI |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | Cambridge, MAUnited States | Analytical testing, Finished drug manufacture | 3013754451 |
| Alnylam US Inc. | Norton, MAUnited States | Analytical testing, Active ingredient (API) manufacture | 3017995758 |
Exclusivity
Patents
48Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| AMVUTTRA | VUTRISIRAN SODIUM | Aug 2028 |
| AMVUTTRA | VUTRISIRAN SODIUM | Dec 2028 |
| AMVUTTRA | VUTRISIRAN SODIUM | Dec 2029 |
| AMVUTTRA | VUTRISIRAN SODIUM | Nov 2032 |
| AMVUTTRA | VUTRISIRAN SODIUM | Aug 2035 |
| AMVUTTRA | VUTRISIRAN SODIUM | Jul 2036 |
| GIVLAARI | GIVOSIRAN SODIUM | Aug 2028 |
| GIVLAARI | GIVOSIRAN SODIUM | Dec 2028 |
| GIVLAARI | GIVOSIRAN SODIUM | Dec 2029 |
| GIVLAARI | GIVOSIRAN SODIUM | Mar 2033 |
| GIVLAARI | GIVOSIRAN SODIUM | Nov 2033 |
| GIVLAARI | GIVOSIRAN SODIUM | Oct 2034 |
| ONPATTRO | PATISIRAN SODIUM | Oct 2027 |
| ONPATTRO | PATISIRAN SODIUM | Apr 2029 |
| ONPATTRO | PATISIRAN SODIUM | Oct 2029 |
| ONPATTRO | PATISIRAN SODIUM | Oct 2030 |
| ONPATTRO | PATISIRAN SODIUM | Nov 2030 |
| ONPATTRO | PATISIRAN SODIUM | Aug 2032 |
| ONPATTRO | PATISIRAN SODIUM | Aug 2035 |
| OXLUMO | LUMASIRAN SODIUM | Aug 2028 |
| OXLUMO | LUMASIRAN SODIUM | Dec 2028 |
| OXLUMO | LUMASIRAN SODIUM | Dec 2029 |
| OXLUMO | LUMASIRAN SODIUM | Dec 2034 |
| OXLUMO | LUMASIRAN SODIUM | Aug 2035 |
| OXLUMO | LUMASIRAN SODIUM | Oct 2035 |
| OXLUMO | LUMASIRAN SODIUM | Nov 2038 |
Catalogue
Marketed products
4Showing 4 of 4.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| AMVUTTRA | VUTRISIRAN | INJECTION | NDA |
| GIVLAARI | givosiran sodium | INJECTION, SOLUTION | NDA |
| OXLUMO | lumasiran | INJECTION, SOLUTION | NDA |
| Onpattro | patisiran | INJECTION, LIPID COMPLEX | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.